目的 通過(guò)文獻(xiàn)計(jì)量學(xué)，總結(jié)分析霍山石斛近20年的研究現(xiàn)狀和未來(lái)發(fā)展的趨勢(shì)。方法 檢索中國(guó)學(xué)術(shù)期刊全文數(shù)據(jù)庫(kù)（CNKI）、萬(wàn)方數(shù)據(jù)庫(kù)（Wanfang Data）、維普生物醫(yī)學(xué)數(shù)據(jù)庫(kù)（VIP）、PubMed、Web of Science（WOS）核心數(shù)據(jù)庫(kù)中2003年1月1日—2023年12月31日的霍山石斛相關(guān)文獻(xiàn)，Endnote進(jìn)行文獻(xiàn)處理，去除不相關(guān)及重復(fù)文獻(xiàn)，利用VOSviewer進(jìn)行文獻(xiàn)計(jì)量及可視化分析。結(jié)果 霍山石斛20年來(lái)中文文獻(xiàn)和英文文獻(xiàn)發(fā)表量均呈波動(dòng)式上升，在數(shù)量及時(shí)間上，中文文獻(xiàn)比英文文獻(xiàn)更具優(yōu)勢(shì)；關(guān)鍵詞聚類(lèi)分析顯示，首先以霍山石斛培育相關(guān)研究為主，其次是活性成分及藥理作用，臨床應(yīng)用及分子生藥學(xué)研究較少。結(jié)論 霍山石斛培育的相關(guān)研究較為成熟，臨床應(yīng)用及分子生藥學(xué)方面研究較少，具有完善及深入研究的價(jià)值。

Objective In order to understand the research status and future research trends of Dendrobium huoshanense in the past 20 years, and provide a certain reference basis for subsequent research. Methods The literature in China Academic Journal Full-text Database (CNKI), Wanfang Database (Wanfang Data), VIP Biomedical Database (VIP), PubMed database and Web of Science (WOS) database from January 1, 2003 to December 31, 2023 were searched. Endnote conducts literature processing to remove irrelevant and duplicate literature, and conducted bibliometric and visual analysis using VOS viewer. Results The results showed that the annual number of publications in the field of D. huoshanense related research was fluctuating upward trend in the past 20 years. In terms of quantity and time, Chinese literature has more advantages than English literature. The keyword clustering analysis indicates that the current research on D. huoshanense was mainly based on cultivation of D. huoshanense and is limited research on clinical applications and molecular pharmacology. Conclusion The clinical application and molecular pharmacology research of D. huoshanense have the significance of comprehensive and in-depth research.

R932

國(guó)家自然科學(xué)基金資助項(xiàng)目（82204805）;安徽省藥食同源天然資源開(kāi)發(fā)與利用工程實(shí)驗(yàn)室開(kāi)放基金項(xiàng)目（YSTY2022009）;安徽省中藥特色技術(shù)人才培養(yǎng)項(xiàng)目（皖衛(wèi)中醫(yī)藥發(fā)【2020】1號(hào)）;安徽中醫(yī)藥大學(xué)第二附屬醫(yī)院“杏林英才”培育計(jì)劃項(xiàng)目（2023-0500-48-46）